In the digitized medicine of tomorrow, drug development is changing through personalized therapies. The patient of the 21st century requires individual drug dosages for optimal treatment results. GoaTam implements this idea with their doProne pharmaceutical 3D printer. The printer enables the sustainable and economical production of personalized drugs in small quantities and individual dosages. With doProne, GoatAM is aimed at pharmaceutical companies, hospital pharmacies and contract manufacturers. In the long term, nationwide, decentralized production in public pharmacies could be made possible. In addition to medicines, the doProne is also suitable for the production of personalized dietary supplements and lifestyle products.

‍

‍